We are live on
!
Find out more
Barrow, Hanley, Mewhinney & Strauss Portfolio holdings
AUM
$30.5B
1-Year Est. Return
29.95%
This Fund
S&P 500
This Quarter
Est. Return
+2.51%
1 Year Est. Return
+29.95%
3 Year Est. Return
+81.25%
5 Year Est. Return
+106.98%
10 Year Est. Return
+342.87%
AUM
$65.8B
AUM Growth
-$609M
(-0.92%)
Cap. Flow
-$1.95B
Cap. Flow
% of AUM
-2.96%
Top 10 Holdings %
Top 10 Hldgs %
26.66%
Holding
463
New
37
Increased
104
Reduced
124
Closed
27
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Dollar General
DG
|
+$352M |
| 2 |
DD
Du Pont De Nemours E I
DD
|
+$278M |
| 3 |
Lowe's Companies
LOW
|
+$208M |
| 4 |
ESRX
Express Scripts Holding Company
ESRX
|
+$169M |
| 5 |
TFCFA
Twenty-First Century Fox, Inc. Class A
TFCFA
|
+$136M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Target
TGT
|
+$447M |
| 2 |
Honeywell
HON
|
+$387M |
| 3 |
Carnival Corporation Ltd
CCL
|
+$353M |
| 4 |
Ameriprise Financial
AMP
|
+$275M |
| 5 |
Ford
F
|
+$241M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 22.36% |
| 2 | Financials | 19.85% |
| 3 | Industrials | 13.12% |
| 4 | Energy | 10.32% |
| 5 | Technology | 9.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Philip Morris
PM
$301B
| $2.04B | 3.11% |
17,406,455
-277,394
| -2% | -$32.1M |
|
2
Wells Fargo
WFC
$261B
| $1.92B | 2.91% |
34,567,119
+225,433
| +0.7% | +$12.1M |
|
3
Johnson Controls International
JCI
$87.5B
| $1.86B | 2.82% |
42,885,451
+2,797,023
| +7% | +$117M |
|
4
JPMorgan Chase
JPM
$939B
| $1.81B | 2.74% |
19,751,247
-688,348
| -3% | -$59.4M |
|
5
Oracle
ORCL
$331B
| $1.78B | 2.71% |
35,577,412
-1,527,435
| -4% | -$69.6M |
|
6
Medtronic
MDT
$107B
| $1.75B | 2.65% |
19,685,524
-520,335
| -3% | -$43.9M |
|
7
Johnson & Johnson
JNJ
$635B
| $1.64B | 2.49% |
12,372,873
-327,972
| -3% | -$41.8M |
|
8
Cardinal Health
CAH
$53.4B
| $1.62B | 2.47% |
20,846,948
+141,935
| +0.7% | +$10.7M |
|
9
RTX Corp
RTX
$287B
| $1.58B | 2.4% |
20,537,180
-417,837
| -2% | -$31.3M |
|
10
Pfizer
PFE
$140B
| $1.55B | 2.36% |
48,764,818
+3,616,177
| +8% | +$114M |
|
11
Altria Group
MO
$122B
| $1.54B | 2.34% |
20,674,309
-258,585
| -1% | -$18.9M |
|
12
Bank of America
BAC
$435B
| $1.52B | 2.3% |
62,525,770
-2,887,113
| -4% | -$67.3M |
|
13
Air Products & Chemicals
APD
$66.3B
| $1.41B | 2.13% |
9,824,433
+172,987
| +2% | +$24.6M |
|
14
American Express
AXP
$223B
| $1.4B | 2.13% |
16,624,368
-321,140
| -2% | -$25.4M |
|
15
Qualcomm
QCOM
$176B
| $1.39B | 2.11% |
25,175,774
+2,410,716
| +11% | +$135M |
|
16
CVS Health
CVS
$137B
| $1.37B | 2.08% |
17,044,120
-356,879
| -2% | -$28.2M |
|
|
ESRX
17
DELISTED
Express Scripts Holding Company
ESRX
| $1.3B | 1.97% |
20,307,241
+2,694,407
| +15% | +$169M |
|
18
BP
BP
$113B
| $1.29B | 1.96% |
42,093,234
-1,858,559
| -4% | -$57.8M |
|
19
ConocoPhillips
COP
$147B
| $1.29B | 1.96% |
29,366,105
-609,553
| -2% | -$28.4M |
|
20
Phillips 66
PSX
$82.9B
| $1.27B | 1.93% |
15,341,160
+991,345
| +7% | +$77.8M |
|
21
Verizon
VZ
$194B
| $1.26B | 1.91% |
28,154,205
-1,988,172
| -7% | -$92.6M |
|
22
Elevance Health
ELV
$81.9B
| $1.25B | 1.9% |
6,645,303
-891,661
| -12% | -$160M |
|
23
Sanofi
SNY
$104B
| $1.21B | 1.84% |
25,306,756
-4,111,725
| -14% | -$197M |
|
24
Microsoft
MSFT
$2.84T
| $1.17B | 1.78% |
17,016,421
-407,026
| -2% | -$27.9M |
|
25
Citigroup
C
$222B
| $1.09B | 1.66% |
16,342,721
-2,456,936
| -13% | -$151M |
|
Similar funds
Barrow, Hanley, Mewhinney & Strauss's Q2 2017 Portfolio in Review
As of Q2 2017, Barrow, Hanley, Mewhinney & Strauss held 463 positions worth $65.8B, down 0.92% from $66.4B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Barrow, Hanley, Mewhinney & Strauss's Q2 2017 filing shows 37 new, 104 increased, 124 reduced and 27 closed positions. Its largest new stake was Healthpeak Properties: 2,383,013 shares worth $76.2M. The largest sale was Target, an estimated $447M.
By sector, the portfolio is most concentrated in Healthcare at 22% of assets, up from 22% a quarter earlier, followed by Financials and Industrials.
- Barrow, Hanley, Mewhinney & Strauss's largest Q2 2017 buy was Healthpeak Properties: 2,383,013 shares worth $76.2M.
- Barrow, Hanley, Mewhinney & Strauss added most to Dollar General in Q2 2017, an estimated $352M increase.
- Barrow, Hanley, Mewhinney & Strauss's biggest Q2 2017 reduction was Target, cutting an estimated $447M.
- Barrow, Hanley, Mewhinney & Strauss fully exited RH in Q2 2017, selling an estimated $89.8M.
- Barrow, Hanley, Mewhinney & Strauss's ten largest holdings make up 27% of its $65.8B portfolio in Q2 2017.
- Barrow, Hanley, Mewhinney & Strauss opened 37 new positions and closed 27 in Q2 2017.
- Barrow, Hanley, Mewhinney & Strauss's portfolio value fell 0.92% quarter-over-quarter to $65.8B.
Based on Barrow, Hanley, Mewhinney & Strauss's 13F filing for Q2 2017, filed 11 Aug 2017.